Venclexta (Venetoclax Vials) 100mg

Venetoclax 100mg vials are prescribed for chronic lymphocytic leukemia and small lymphocytic lymphoma. This oral targeted therapy belongs to the BCL-2 inhibitor class. Store at ambient temperature and follow handling instructions carefully.

Strength

100mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Abbvie US LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Venetoclax 100mg vials are used to treat adults with chronic lymphocytic leukemia or small lymphocytic lymphoma. It works by blocking a protein that helps cancer cells survive. Patients often ask what is venetoclax used for; it targets specific pathways in blood cancers. The medication is part of targeted therapy regimens for certain hematologic malignancies.

Side Effects

Venetoclax 100mg vials may cause common effects such as nausea, fatigue, or low white blood cell counts. Some patients report diarrhea or upper respiratory infections during treatment. These effects vary by individual and should be monitored by a healthcare provider. Regular blood tests help track how the body responds to the medication.

Precautions & Warnings

Venetoclax 100mg vials require careful handling and storage at ambient temperature. Avoid exposure to extreme heat or cold. Patients should follow dosing schedules precisely and attend all scheduled medical appointments. Keep out of reach of children and pets. Do not use if the vial is damaged or expired.

Avoid Interactions

Venetoclax 100mg vials can interact with other medications, including strong CYP3A inhibitors or inducers. Grapefruit products may also affect how the drug works. Patients should inform their doctor about all prescription, over-the-counter, and herbal products they use. Alcohol use may increase certain side effects and should be discussed with a healthcare provider.

Frequently Asked Questions

Venetoclax is used to treat chronic lymphocytic leukemia and small lymphocytic lymphoma in adults.

Store venetoclax 100mg vials at ambient temperature and protect from extreme conditions.

Venetoclax is available by prescription only; consult a licensed healthcare provider for access.

Common effects may include nausea, fatigue, or low white blood cell counts.

Yes, it may interact with CYP3A inhibitors, inducers, or grapefruit products.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.